Alexopoulos GS, et al. “Vascular depression” hypothesis. Arch Gen Psychiatry. 1997;54(10):915–22. https://doi.org/10.1001/archpsyc.1997.01830220033006.

Article  CAS  PubMed  Google Scholar 

Taylor WD, et al. Perspectives on the management of vascular depression. Am J Psychiatry. 2018;175(12):1169–75. https://doi.org/10.1176/appi.ajp.2018.18050568.

Article  PubMed  PubMed Central  Google Scholar 

Jellinger KA. The enigma of vascular depression in old age: a critical update. J Neural Transm (Vienna, Austria: 1996). 2022;129(8):961–76. https://doi.org/10.1007/s00702-022-02521-5.

Article  Google Scholar 

Aizenstein HJ, et al. Vascular depression consensus report—a critical update. BMC Med. 2016. https://doi.org/10.1186/s12916-016-0720-5.

Article  PubMed  PubMed Central  Google Scholar 

Loganathan S, et al. Progression of vascular depression to possible vascular dementia. J Neuropsychiatry Clin Neurosci. 2010;22(4):451.e434-451.e435. https://doi.org/10.1176/jnp.2010.22.4.451.e34.

Article  Google Scholar 

Chen RH, et al. Investigation and analysis of sleep status in patients with vascular depression. Int J Gerontol. 2018;12(4):299–302. https://doi.org/10.1016/j.ijge.2017.11.004.

Article  Google Scholar 

Vasic N, et al. Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study. J Psychiatry Neurosci. 2015;40(6):412–21. https://doi.org/10.1503/jpn.140246.

Article  PubMed  PubMed Central  Google Scholar 

Greene J, et al. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology. 2009;34(11):2459–68. https://doi.org/10.1038/npp.2009.68.

Article  CAS  PubMed  Google Scholar 

Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry. 2006;60(12):1304–5. https://doi.org/10.1016/j.biopsych.2006.09.006.

Article  PubMed  Google Scholar 

Mccarley RW, et al. Brainstem neuromodulation and REM sleep. Semin Neurosci. 1995;7(5):341–54.

Article  CAS  Google Scholar 

El Mansari M, et al. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp Brain Res. 1989;76(3):519–29. https://doi.org/10.1007/bf00248908.

Article  PubMed  Google Scholar 

Bonaventure P, et al. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder. J Pharmacol Exp Ther. 2012;342(2):429–40. https://doi.org/10.1124/jpet.112.193995.

Article  CAS  PubMed  Google Scholar 

Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med. 2000;62(3):326–36. https://doi.org/10.1097/00006842-200005000-00006.

Article  CAS  PubMed  Google Scholar 

Chen R, et al. Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: a prospective randomized clinical trial. J Psychiatr Res. 2023;159:274–82. https://doi.org/10.1016/j.jpsychires.2022.12.023.

Article  PubMed  Google Scholar 

Okada M, et al. Effects of subchronic administrations of vortioxetine, lurasidone, and escitalopram on thalamocortical glutamatergic transmission associated with serotonin 5-HT7 receptor. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22031351.

Article  PubMed  PubMed Central  Google Scholar 

Sleight AJ, et al. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol. 1995;47(1):99–103.

Article  CAS  PubMed  Google Scholar 

Prisco S, Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol. 1995;116(2):1923–31. https://doi.org/10.1111/j.1476-5381.1995.tb16684.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edinoff AN, et al. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol Int. 2021;13(3):387–401. https://doi.org/10.3390/neurolint13030038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy SE, et al. The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action. Lancet Psychiatry. 2021;8(9):824–35. https://doi.org/10.1016/S2215-0366(21)00154-1.

Article  PubMed  Google Scholar 

Kátai Z, et al. Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation. Psychopharmacology. 2013;228(3):439–49. https://doi.org/10.1007/s00213-013-3046-4.

Article  CAS  PubMed  Google Scholar 

Smith ALW, et al. The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression. CNS Drugs. 2023;37(7):571–85. https://doi.org/10.1007/s40263-023-01014-7.

Article  CAS  PubMed  Google Scholar 

Tsutsui R, et al. Effects of the 5-HT(1A) receptor agonist tandospirone on ACTH-induced sleep disturbance in rats. Biol Pharm Bull. 2015;38(6):884–8. https://doi.org/10.1248/bpb.b14-00887.

Article  CAS  PubMed  Google Scholar 

Chen H, et al. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: a pilot randomized controlled trial at a single-center in China. J Psychiatr Res. 2019;114:133–40. https://doi.org/10.1016/j.jpsychires.2019.04.024.

Article  PubMed  Google Scholar 

Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. 2013. https://doi.org/10.1176/appi.books.9780890425596.

Knesevich JW, et al. Validity of the Hamilton Rating Scale for depression. Br J Psychiatry. 1977;131(1):49–52. https://doi.org/10.1192/bjp.131.1.49.

Article  CAS  PubMed  Google Scholar 

Walsh JH, et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep. 2021;44(11):zsab149. https://doi.org/10.1093/sleep/zsab149.

Article  PubMed  PubMed Central  Google Scholar 

Waern M, et al. Does the Suicide Assessment Scale predict risk of repetition? A prospective study of suicide attempters at a hospital emergency department. Eur Psychiatry. 2010;25(7):421–6. https://doi.org/10.1016/j.eurpsy.2010.03.014.

Article  CAS  PubMed  Google Scholar 

Hsueh YJ, et al. Psychometric properties of the Chinese version of the Michigan Alcoholism Screening Test (MAST-C) for patients with alcoholism. Perspect Psychiatr Care. 2014;50(2):83–92. https://doi.org/10.1111/ppc.12022.

Article  PubMed  Google Scholar 

Morisky DE, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54. https://doi.org/10.1111/j.1751-7176.2008.07572.x.

Article  PubMed  Google Scholar 

Nimh. Treatment emergent symptoms scale. Psychopharmacol Bull. 1985;21:1069–73.

Stein DJ, Lopez AG. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Adv Ther. 2011;28(11):1021–37. https://doi.org/10.1007/s12325-011-0071-8.

Article  PubMed  Google Scholar 

Hintze JP, Gault D. Escitalopram for recurrent isolated sleep paralysis. J Sleep Res. 2020;29(6): e13027. https://doi.org/10.1111/jsr.13027.

Article  PubMed